Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
About the study
This randomized multi-center study is intended to compare different coatings on stents for treatment of lesions of the above-the-knee femoropopliteal artery.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- One de novo or restenosed artherosclerotic lesion with ≥ 50% diameter stenosis
- Symptoms of peripheral arterial disease (Rutherford 2-4)
EXCLUSION CRITERIA
Exclusion Criteria:
- Pregnant, breastfeeding, or planning to become pregnant in the next 5 years
- Less than 18 years old
- Medical condition or disorder that would limit life expectancy to less than 12 months or that may cause noncompliance with the protocol or confound the data analysis
- Previous stent in the study vessel
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Peripheral Arterial Disease (PAD)
Age (in years)
18+
Phase
Not Applicable
Participants needed
176
Est. Completion Date
Jan 31, 2024
Treatment type
Interventional
Sponsor
Cook Group Incorporated
ClinicalTrials.gov identifier
NCT02936622
Study number
13-002
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?